ISB News

Lee Hood Will Speak at ‘Xconomy Forum: Seattle Biotech Seizes the Momentum’

Dr. Lee Hood will be one of the featured speakers during the next Xconomy Forum on Seattle’s biotech revival. The event takes place on May 6 at Fred Hutchinson Cancer Research Center.

For full details, visit the event page. Promo code: Use XconFriend to get a discount at registration.

Biotech has roared back to life the past couple years, perhaps more than any other U.S. economic sector. Seattle’s biotech community is no different. Last year’s signs of revival include the ascendance of Juno Therapeutics, the burgeoning pipeline of Seattle Genetics, the kickoff of a study that could become a key part of the national precision medicine initiative, and Celgene’s decision to build an R&D center in town.

How should Seattle biotech seize the momentum? Join us at the Fred Hutchinson Cancer Research Center to take part in the discussion.

Confirmed Speakers:

  • Gary Gilliland, President and Director, Fred Hutchinson Cancer Research Center
  • Randy Schatzman, CEO, Alder Biopharmaceuticals
  • Lee Hood, President, The Institute for Systems Biology
  • Chad Robins, President and CEO, Adaptive Biotechnologies
  • Bob Nelsen, Co-founder and Managing Director, ARCH Venture Partners
  • Heather Franklin, CEO, Blaze Bioscience
  • Hans Bishop, CEO, Juno Therapeutics
  • Charlotte Hubbert, Program Investment Officer, The Bill & Melinda Gates Foundation
  • Vikram Jandhyala, Vice President for Innovation, UW Center for Commercialization
  • Matt McIlwain, Managing Director, Madrona Venture Group
  • Mike Gallatin, Senior Advisor, Frazier Healthcare

Recent Articles

  • Valerie Logan Luncheon emcee Heather Logan

    ‘Innovation to Impact:’ 8th Annual Valerie Logan Luncheon Shines Light on ISB Education

    The 8th Annual Valerie Logan Luncheon celebrated ISB Education’s mission of engaging entire school systems — from principals and administrators to teachers and students — to ensure all students are STEM literate. Nearly 100 people attended the event at ISB, and generously gave more than $100,000 for ISB Education.

  • Malaria Researchers’ Findings May Have Implications for Preventing Spread of Deadly Disease

    ISB researchers and their collaborators are using systems biology approaches to learn how the malaria parasite is able to transfer to humans via the bite of an infected mosquito. The information they have uncovered may help identify new ways to prevent people from contracting the deadly disease.

  • ISB Unveils New Brand Ahead of 20th Anniversary

    We created a new brand identity — including logo and tag line — to reflect ISB’s evolution since our inception in 2000, and ahead of our 20th anniversary. ISB is proud to be a part of the vibrant research community in Seattle, and is committed to translational and collaborative science.